<DOC>
	<DOCNO>NCT00369993</DOCNO>
	<brief_summary>Spacers use people respiratory disease problem use MDIs ( meter dose inhaler ) . This study use fluticasone propionate/salmeterol look pharmacokinetic profile produce different spacers wash un-washed state .</brief_summary>
	<brief_title>Spacer Comparison In Adult Asthmatics</brief_title>
	<detailed_description>A randomised , open label , five-way crossover study assess systemic exposure fluticasone propionate salmeterol SERETIDE™/ADVAIR™ 250 HFA MDI without spacer AeroChamber-Max spacer VOLUMATIC™ wash unwashed state adult subject mild intermittent asthma .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<criteria>Inclusion criterion : Nonsmoking BMI 19 30 Diagnosed mild intermittent asthma take medication . Exclusion criterion : Taking oral corticosteroid inhale fluticasone propionate Have certain medical condition otherwise healthy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>asthma</keyword>
	<keyword>spacer</keyword>
</DOC>